Clinical Trial Update: A Phase 2a Study to Evaluate the Safety, Tolerability, Pharmacodynamics and Efficacy of AG011 in Ulcerative Colitis [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for AG011 in ulcerative colitis, reporting completion of Phase 1/Phase 2a evaluation of safety, tolerability, pharmacodynamics and efficac…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• AG011

Snippet

Sponsor: ActoGeniX N.V. | Conditions: Moderately Active Ulcerative Colitis | Phase 1, Phase 2 | Status: COMPLETED